Beroni Group Limited Published Article on the FEBS Journal

Sydney, Australia (ABN Newswire) - Beroni Group Limited (OTCMKTS:BNIGF) (NSX:BTG), an Australia-based biopharmaceutical enterprise, today announced that its article entitled "Crystal structures of the SARS-CoV-2 nucleocapsid protein C-terminal domain and development of nucleocapsid-targeting nanobodies" has been accepted for publication and undergone full review in the FEBS Journal.

The FEBS Journal is an international peer-reviewed non-profit society journal devoted to publishing high-quality papers reporting significant advances in the molecular life sciences.

The published article is related to the scientific findings derived from Beroni's current research of the development of a medical solution using single-domain antibodies (sdAbs) for the SARS-CoV-2 coronavirus. The Company has identified 2 crystal structures of nucleocapsid protein C-terminal domain. Nucleocapsid protein is a major structural protein of SARS-CoV-2 and plays an important role in viral RNA packing, replication, assembly, and infection. Through screening a sdAbs library, the scientific team has identified four sdAbs targeting different regions of nucleocapsid protein with high affinities that have future potential to be used in viral detection and therapeutic purposes.

"We are delighted to progress further in our coronavirus research program and to publish our new findings in the FEBS journal. The Company plans to carry out a series of experiments to gradually transform the results into clinical trials and find a new way for the diagnosis and treatment of the new coronavirus. Beroni hopes our efforts can contribute to the basic understanding of the SARS-CoV-2 coronavirus and the global development of antiviral drugs." said Jacky Zhang, Chairman and CEO of Beroni Group.

The full article can be viewed at:
https://www.abnnewswire.net/lnk/33G6S6JT



About Beroni Group Limited:  

Beroni Group (NSX:BTG) (OTCMKTS:BNIGF) is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. Its diversified portfolio is comprised of a US FDA approved virus diagnostic kit, an e-commerce platform for the sale of pharmaceutical products and a development pipeline targeting oncology and cell therapies. Beroni has operations in Australia, United States, China and Japan. To learn more about Beroni, please visit www.beronigroup.com.



Source:
Beroni Group Limited



Contact:
Dragon Gate Investment Partners LLC
Tel: +1(646)-801-2803
Email: BNIGF@dgipl.com

News Provided by ABN Newswire via QuoteMedia

The Conversation (0)

Newmont Announces Agreement to Divest CC&V for up to $275 Million

Divestitures Announced to Date to Generate up to $3.9 Billion in Gross Proceeds

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Wheaton Precious Metals Announces the Acquisition of a Gold Stream from Allied Gold's Kurmuk Project

 Wheaton Precious Metals™ Corp. ("Wheaton" or the "Company") is pleased to announce that its wholly-owned subsidiary, Wheaton Precious Metals International Ltd. ("WPMI") has entered into a definitive Precious Metals Purchase Agreement (the "Gold Stream") with Allied Gold Corporation and its wholly owned subsidiary Allied Gold Services Inc. (together, "Allied"), in respect of the Kurmuk Project located in Ethiopia (the "Project" or "Kurmuk").

"Wheaton is pleased to announce a streaming agreement with Allied to advance the construction of the Kurmuk project, which is set to be the first commercial gold mine in Ethiopia ," said Randy Smallwood , President and CEO of Wheaton Precious Metals. "This fully permitted, high quality development project offers significant exploration potential, supported by a team at Allied with a proven operating track record. We are excited to partner with Allied to unlock opportunities that empower the local communities and help drive the growth of Ethiopia's emerging metals and mining sector."

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Adrian Day, gold bars.

Adrian Day: US$2,500 Gold? Pullback Would be "Healthy," Reasons to Buy Remain

The gold price has seen ups and downs since the US election.

The yellow metal took a hit directly after Donald Trump's victory, falling to the US$2,550 per ounce level. But then it staged a quick recovery, passing US$2,700. It's now pulled back again, currently at around US$2,650.

Ahead of gold's second post-election decline, Adrian Day, president of Adrian Day Asset Management, told the Investing News Network he wouldn't be surprised to see another leg down.

Keep reading...Show less
Gareth Soloway, gold, silver and Bitcoin.

Gareth Soloway: Gold, Silver, Bitcoin and More — Price Predictions for 2025

Speaking to the Investing News Network, Gareth Soloway, chief market strategist at VerifiedInvesting.com, shared his latest price forecasts for gold and silver, as well as Bitcoin.

Heading into 2025, he said he thinks the yellow metal will be the year's best-performing asset.

"I would have to take gold — and again, for me it's the risk that if we go to US$107,000 on Bitcoin, let's say, we could pull back to US$75,000 next year ... that drawdown is a hefty drawdown of 30 percent or so at that point," he said.

Keep reading...Show less

Latest Press Releases

Related News

×